Clinical trial results for
non-small cell lung
cancer (NSCLC)
See results for OPDIVO immunotherapy, alone or in combination with other therapies
Actor portrayals.
Advanced NSCLC
OPDIVO + YERVOY
For certain adults with previously untreated advanced NSCLC that tests positive for PD-L1
Advanced NSCLC
OPDIVO + YERVOY with limited chemotherapy
For adults with previously untreated advanced NSCLC
Early-stage NSCLC before and after surgery
OPDIVO with chemotherapy followed by OPDIVO alone
For adults with early-stage NSCLC, before and after surgery
Early-stage NSCLC before surgery
OPDIVO with chemotherapy
For adults with early-stage NSCLC before surgery
Previously treated advanced NSCLC
OPDIVO
For adults who have had prior treatments for NSCLC
OPDIVO, OPDIVO-based combination treatments, OPDIVO Qvantig, and OPDIVO Qvantig-based combination treatments will not work for everyone. Individual results may vary.
Getting treatment
See treatment plans and what to expect from an intravenous (IV) infusion or under-the-skin injection (subcutaneous injection)